232120 Sigma-AldrichCisplatin - CAS 15663-27-1 - Calbiochem
Cisplatin - CAS 15663-27-1, is a platinum coordination complex with potent anti-neoplastic activity. Induces apoptosis in cancer cells, possibly via caspase-3 activation.
More>> Cisplatin - CAS 15663-27-1, is a platinum coordination complex with potent anti-neoplastic activity. Induces apoptosis in cancer cells, possibly via caspase-3 activation. Less<<Sinónimos: CPDC, DDP, cis-Diaminedichloroplatinum
Productos recomendados
Descripción
Replacement Information |
---|
Tabla espec. clave
CAS # | Empirical Formula |
---|---|
15663-27-1 | Pt(NH₃)₂Cl₂ |
Products
Número de referencia | Embalaje | Cant./Env. | |
---|---|---|---|
232120-50MG | Frasco de vidrio | 50 mg |
Product Information | |
---|---|
CAS number | 15663-27-1 |
ATP Competitive | N |
Form | Yellow solid |
Hill Formula | Pt(NH₃)₂Cl₂ |
Chemical formula | Pt(NH₃)₂Cl₂ |
Reversible | N |
Structure formula Image | |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Primary Target | Induces apoptosis in cancer cells |
Purity | ≥98% by HPLC |
Physicochemical Information | |
---|---|
Cell permeable | N |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS | |
---|---|
RTECS | TP2450000 |
Product Usage Statements |
---|
Packaging Information |
---|
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Número de referencia | GTIN |
232120-50MG | 04055977217605 |
Documentation
Cisplatin - CAS 15663-27-1 - Calbiochem Ficha datos de seguridad (MSDS)
Título |
---|
Cisplatin - CAS 15663-27-1 - Calbiochem Certificados de análisis
Cargo | Número de lote |
---|---|
232120 |
Referencias bibliográficas
Visión general referencias |
---|
Hall, M.D., et al. 2014. Cancer Res. In press. Duan, L., et al. 2001. J. Neurooncol. 52, 23. Mese, H., et al. 2000. Cancer Chemother. Pharmacol. 46, 241. Von Hoff, D.D., and Rozencweig, M. 1979. in Adv. Pharmacol. Chemother. 16, 279. |